{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:28:14Z","timestamp":1778250494854,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.eururo.2003.12.014","type":"journal-article","created":{"date-parts":[[2004,1,23]],"date-time":"2004-01-23T10:18:16Z","timestamp":1074853096000},"page":"465-470","source":"Crossref","is-referenced-by-count":18,"title":["Conservative Management of Mucosal Prostatic Urethral Involvement in Patients with Superficial Transitional Cell Carcinoma of the Bladder"],"prefix":"10.1016","volume":"45","author":[{"given":"A.Erdem","family":"Canda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"Tuzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Ugur","family":"Mungan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kutsal","family":"Yorukoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziya","family":"Kirkali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.eururo.2003.12.014_BIB1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0094-0143(21)00639-X","article-title":"Management of the patient with bladder cancer. Urerhral recurrence","volume":"21","author":"Freeman","year":"1994","journal-title":"Urol. Clin. North Am."},{"key":"10.1016\/j.eururo.2003.12.014_BIB2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00326796","article-title":"Transitional cell carcinoma of the prosate: diagnosis, staging and management","volume":"6","author":"Hardeman","year":"1988","journal-title":"World J. Urol."},{"key":"10.1016\/j.eururo.2003.12.014_BIB3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0022-5347(01)66605-9","article-title":"Is pT4a (D1) stage reliable in assessing transitional cell carcinoma involvement of the prostate in patients with concurrent bladder cancer? A necessary distinction for contiguous and noncontiguous involvement","volume":"155","author":"Pagano","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.12.014_BIB4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0022-5347(17)42389-5","article-title":"Superficial transitional cell carcinoma carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Gu\u00e8rin","volume":"139","author":"Hillyard","year":"1988","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.12.014_BIB5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005392-199501000-00020","article-title":"Intravesical bacillus Calmette-Gu\u00e8rin for treatment of superficial transitional cell carcinoma of prostatic urethra in association with carcinoma of the bladder","volume":"153","author":"Schellhammer","year":"1995","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.12.014_BIB6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0090-4295(99)80481-6","article-title":"In situ transitional cell carcinoma involvement of prostatic urethra: bacillus Calmette-Gu\u00e8rin therapy without previous transurethral resection of the prostate","volume":"57","author":"Palou","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2003.12.014_BIB7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0022-5347(17)41031-7","article-title":"Intravesical bacillus Calmette-Gu\u00e8rin therapy for in situ transitional cell carcinoma involving the prostatic urethra","volume":"141","author":"Bretton","year":"1989","journal-title":"J. Urol."},{"issue":"5","key":"10.1016\/j.eururo.2003.12.014_BIB8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0090-4295(89)90314-2","article-title":"Conservative treatment of superficial transitional cell carcinoma of prostatic urethra with intravesical BCG","volume":"34","author":"Orihuela","year":"1989","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2003.12.014_BIB9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000473591","article-title":"Recurrence of superficial tumors in prostatic urethra","volume":"19","author":"Solsona","year":"1991","journal-title":"Eur. Urol."},{"key":"10.1016\/j.eururo.2003.12.014_BIB10","unstructured":"Sobin HL, Wittekind C., editors. Urogenital Tumours. TNM Classification of Malignant Tumours. New York: Wiley; 1997. p 180."},{"key":"10.1016\/j.eururo.2003.12.014_BIB11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0022-5347(17)59998-X","article-title":"Carcinoma in situ of the bladder with associated prostatic involvement","volume":"111","author":"Thelmo","year":"1974","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.12.014_BIB12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/1097-0142(197508)36:2<514::AID-CNCR2820360230>3.0.CO;2-C","article-title":"Further observations on carcinoma in situ of the urinary bladder: silent but extensive intraprostatic involvement","volume":"36","author":"Seemayer","year":"1975","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.eururo.2003.12.014_BIB13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0022-5347(17)45604-7","article-title":"Long term effect of intravesical bacillus Calmette-Gu\u00e8rin on flat carcinoma in situ of the bladder","volume":"135","author":"Herr","year":"1986","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.eururo.2003.12.014_BIB14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0022-5347(17)41585-0","article-title":"Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder","volume":"140","author":"Hardeman","year":"1988","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.eururo.2003.12.014_BIB15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0022-5347(17)51090-3","article-title":"Prostatic recurrences in the management of superficial bladder tumors","volume":"130","author":"Lockhart","year":"1983","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.eururo.2003.12.014_BIB16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-5347(17)42445-1","article-title":"Role of fibronectin in intravesical BCG therapy for superficial bladder cancer","volume":"139","author":"Ratliff","year":"1988","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.eururo.2003.12.014_BIB17","first-page":"961","article-title":"Fine needle aspiration of granulomatous prostatitis induced by BCG immunotherapy of bladder cancer","volume":"29","author":"Stilmant","year":"1985","journal-title":"Acta Cytol."},{"key":"10.1016\/j.eururo.2003.12.014_BIB18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0022-5347(17)45606-0","article-title":"Complications of bacillus Calmette-Gu\u00e8rin immumotherapy in 1278 patients with bladder cancer","volume":"135","author":"Lamm","year":"1986","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.12.014_BIB19","unstructured":"Haaff EO, Catalona WJ, Ratliff TL. Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG."},{"key":"10.1016\/j.eururo.2003.12.014_BIB20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0022-5347(17)38047-3","article-title":"Transitional cell carcinoma of the prostate","volume":"146","author":"Matzkin","year":"1991","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.12.014_BIB21","first-page":"165","article-title":"Carcinoma in situ of the prostatic urethra: the role of intravesical BCG","volume":"6","author":"Palou","year":"2001","journal-title":"Urol. Integr. Invest"},{"key":"10.1016\/j.eururo.2003.12.014_BIB22","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0022-5347(01)66762-4","article-title":"The prostate involvement as prognostic factor in patients with superficial bladder tumors","volume":"154","author":"Solsona","year":"1995","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.12.014_BIB23","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0090-4295(99)80481-6","article-title":"In situ transitional cell carcinoma involvement of the prostatic urethra: bacillus Calmette-Guerin therapy without previous transurethral resection of the prostate","volume":"47","author":"Palou","year":"1996","journal-title":"Urology"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228380300678X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228380300678X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T02:29:52Z","timestamp":1623637792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030228380300678X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S030228380300678X"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2003.12.014","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}